Central laboratory reassessment of IGF-I, IGF-binding protein-3, and GH serum concentrations measured at local treatment centers in growth-impaired children: Implications for the agreement between outpatient screening and the results of somatotropic axis functional testing

European Journal of Endocrinology

Volumn 157, Issue 5, 2007, Pages 597-603

  Hauffa, Berthold P ^a,b   Lehmann, Nils ^b   Bettendorf, Markus ^a   Mehls, Otto ^a   Dörr, Helmuth Günther ^c   Stahnke, Nikolaus ^d   Steinkamp, Heinz ^e   Said, Elfriede ^e   Ranke, Michael B ^f   Andler, W ^g   Arndt, R ^g   Bohles H J ^g   Eisberg, S ^g   Hiort, O ^g   Korsch, E ^g   Mix, M ^g   Mohnike, K ^g   Morlot, M ^g   Muhlenberg R ^g   Partsch, C J ^g   Schonau R ^g   Schwarz, H P ^g   Simic Schleicher, G ^g   Ullrich, K P ^g   van Meegen Freund, T ^g   Vogel, Ch ^g   Klinghammer, A ^g   more..

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d ENDOKRINOLOGIKUM HAMBURG   (Germany)

^e PFIZER INC   (United States)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g Universität Duisburg Essen ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CHEMOLUMINESCENCE; CHILD; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; IMMUNORADIOMETRIC ASSAY; INSULIN HYPOGLYCEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASS SCREENING; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RESCREENING;

EID: 36549059155     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0338     Document Type: Article

References (43)

1. Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T & Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Hormone and IGF Research 2001 11 137-165.
2. Rosenfeld RG, Wilson DM, Lee PD & Hintz RL. Insulin-like growth factors I and II in evaluation of growth retardation. Journal of Pediatrics 1986 109 428-433.
3. Lee PD, Wilson DM, Rountree L, Hintz RL & Rosenfeld RG. Efficacy of insulin-like growth factor I levels in predicting the response to provocative growth hormone testing. Pediatric Research 1990 27 45-51.
4. Phillip M, Chalew SA, Kowarski AA & Stene MA. Plasma IGFBP-3 and its relationship with quantitative growth hormone secretion in short children. Clinical Endocrinology 1993 39 427-432.
5. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A & Clemmons DR. Use of insulin-like growth factor-binding protein-2 (IGFBP- 2), IGFBP-3, and ICF-I for assessing growth hormone status in short children. Journal of Clinical Endocrinology and Metabolism 1993 77 1294-1299.
6. Cianfarani S, Boemi S, Spagnoli A, Cappa M, Argirò G, Vaccaro F, Manca Bitti ML & Boscherini B. Is IGF-binding protein-3 assessment helpful for the diagnosis of GH deficiency. Clinical Endocrinology 1995 43 43-47.
7. Nunez SB, Municchi G, Barnes KM & Rose SR. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children - a clinical research center study. Journal of Clinical Endocrinology and Metabolism 1996 81 1927-1932.
8. Rasat R, Livesey JL, Espiner EA, Abbott GD & Donald RA. IGF-1 and IGFBP-3 screening for disorders of growth hormone secretion. New Zealand Medical Journal 1996 109 156-159.
9. Karachaliou F, Stamoyannou L, Maravelias K, Bartsocas CS & Koutselinis A. Serum levels of IGFBP-3: usefulness in diagnosis of GH deficiency and relationship to measurements of GH secretion in children. Journal of Pediatric Endocrinology and Metabolism 1996 9 169-174.
10. Juul A, Kastrup KW, Pedersen SA & Skakkebaek NE. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3. Journal of Clinical Endocrinology and Metabolism 1997 82 1195-1201.
11. Juul A & Skakkebæk NE. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. Journal of Pediatrics 1997 130 197-204.
12. Koch A & Dorr HG. Insulin-like growth factor-I and its binding protein-3 in serum: are they good screening properties for the diagnosis of growth hormone deficiency? European Journal of Clinical Chemistry and Clinical Biochemistry 1997 35 379-385.
13. Tillmann V, Buckler JMH, Kibirige MS, Price DA, Shalet SM, Wales JKH, Addison MG, Gill MS, Whatmore AJ & Clayton PE. Biochemical tests in the diagnosis of childhood growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1997 82 531-535.
14. Rikken B, Van Doorn J, Ringeling A, Van den Brande JL, Massa G & Wit JM. Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Hormone Research 1998 50 166-176.
15. Mitchell H, Dattani MT, Nanduri V, Hindmarsh PC, Preece MA & Brook CGD. Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency. Archives of Disease in Childhood 1999 80 443-447.
16. Ranke MB, Schweizer R, Elmlinger MW, Weber K, Binder G, Schwarze CP & Wollmann HA. Significance of basal IGF-I, IGFBP-3 and IGFBP-2 measurements in the diagnostics of short stature in children. Hormone Research 2000 54 60-68.
17. Boquete HR, Sobrado PG, Fideleff HL, Sequera AM, Giaccio AV, Suarez MG, Ruibal GF & Miras M. Evaluation of diagnostic accuracy of insulin-like growth factor (IGF)-I and IGF-binding protein-3 in growth hormone-deficient children and adults using ROC plot analysis. Journal of Clinical Endocrinology and Metabolism 2003 88 4702-4708.
18. Badaru A & Wilson DM. Alternatives to growth hormone stimulation testing in children. Trends in Endocrinology and Metabolism 2004 15 252-258.
19. Darendeliler F, Spinu I, Bas F, Bundak R, Isguven P, Arslanoglu I, Saka N, Sukur M & Gunoz H. Reevaluation of growth hormone deficiency during and after growth hormone (GH) treatment: diagnostic value of GH tests and IGF-I and IGFBP-3 measurements. Journal of Pediatric Endocrinology and Metabolism 2004 17 1007-1012.
20. Hauffa BP, Lehmann N, Bettendorf M, Mehls O, Dorr HG, Partsch CJ, Schwarz HP, Stahnke N, Steinkamp H, Said E, Sander S & Ranke MB. Central reassessment of GH concentrations measured at local treatment centers in children with impaired growth: consequences for patient management. European Journal of Endocrinology 2004 150 291-297.
21. Bland JM & Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995 346 1085-1087.
22. Passing H & Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Journal of Clinical Chemistry and Clinical Biochemistry 1983 21 709-720.
23. Schoonjans F, Zalata A, Depuydt CE & Comhaire FH. MedCalc: a new computer program for medical statistics. Computer Methods and Programs in Biomedicine 1995 48 257-262.
24. Sachs L. Angewandte Statistik, Anwendung Statistischer Methoden Berlin, Heidelberg, New York: Verlag, 1992.
25. SAS System. Release 8.2 Edition Carey, NC: SAS Institute, 2002.
26. Quarmby V, Quan C, Ling V, Compton P & Canova-Davis E. How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy Journal of Clinical Endocrinology and Metabolism 1998 83 1211-1216.
27. Ranke MB, Osterziel KJ, Schweizer R, Schuett B, Weber K, Robbel P, Vornwald A, Blumenstock G & Elmlinger MW. Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays. Clinical Chemistry and Laboratory Medicine 2003 41 1329-1334.
28. Wyatt DT, Mark D & Slyper A. Survey of growth hormone treatment practices by 251 pediatric endocrinologists. Journal of Clinical Endocrinology and Metabolism 1995 80 3292-3297.
29. Reiter EO & Rosenfeld RG. Normal and aberrant growth. In Williams Textbook of Endocrinology, pp 1003-1114. Eds PR Larsen, HM Kronenberg, S Melmed & KS Polonsky, Philadelphia: Saunders, 2002.
30. Lifshitz F. Pediatric Endocrinology, Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders Boca Raton, USA: CRC Press Inc., 2006.
31. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ & Bierich JR. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. Journal of Clinical Endocrinology and Metabolism 1990 70 1292-1298.
32. Hasegawa Y, Hasegawa T, Takada M & Tsuchiya Y. Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents. European Journal of Endocrinology 1996 134 184-189.
33. Juul A. Determination of insulin-like growth factor I in children: normal values and clinical use. Hormone Research 2001 55 94-99.
34. Blum WF & Schweizer R. Insulin-like growth factors and their binding proteins. In Diagnostics of Endocrine Function in Children and Adolescents, pp 166-199. Ed. MB Ranke, Basel: Karger, 2003.
35. Kao PC, Matheny AP, Jr & Lang CA. Insulin-like growth factor I comparisons in healthy twin children. Journal of Clinical Endocrinology and Metabolism 1994 78 310-312.
36. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Tolvanen L, Koskenvuo M, Leinonen P, Koistinen R & Seppälä M. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. Journal of Clinical Investigation 1996 98 2612-2615.
37. Clemmons DR & Van Wyk JJ. Factors controlling blood concentration of somatomedin C. Clinics in Endocrinology and Metabolism 1984 13 113-143.
38. Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG & Thorner MO. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. Journal of Clinical Investigation 1988 81 968-975.
39. Kratzsch J, Blum WF, Schenker E & Keller E. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF-binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis. Experimental and Clinical Endocrinology and Diabetes 1995 103 285-291.
40. Holt RI, Jones JS, Stone NM, Baker AJ & Miell JP. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation. Journal of Clinical Endocrinology and Metabolism 1996 81 160-168.
41. Blum WF. Insulin-like growth factors (IGFs) and IGF-binding proteins in chronic renal failure: evidence for reduced secretion of IGFs. Acta Paediatrica Scandinavica 1991 379 24-31.
42. Van Wyk JJ & Bruton ET. Molecular basis for species and ligand specificity of a monoclonal antibody raised against human IGF-I. Endocrinology 1997 138 4521-4523.
43. Hilczer M, Smyczynska J, Stawerska R & Lewinski A. Stability of IGF-I concentration despite divergent results of repeated GH stimulating tests indicates poor reproducibility of test results. Endocrine Regulations 2006 40 37-45.